Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extracorporeal Cytokine Hemoadsorption in Septic Shock and Cirrhosis
NCT03866083Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2019
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in septic shock, sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Reversal of shock at 72 hours. Status: unknown.
02
Conditions
septic shock
Beyond the preview
Go deeper on NCT03866083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866083.